Beam Therapeutics

In News

Wedbush Remains a Buy on Beam Therapeutics (BEAM) - The Globe and Mail

The Globe and Mail - Feb 13, 2026

Beam Therapeutics Secures Standby License for Key Patents - TipRanks

TipRanks - Feb 12, 2026

Touching base: Beam CEO on gene editing biotech's 'big push' for in vivo delivery - Fierce Biotech

Fierce Biotech - Jan 21, 2026

Best CRISPR Companies to Buy in 2026 and How to Invest in Them - The Motley Fool

The Motley Fool - Feb 12, 2026

FMR LLC's Strategic Acquisition of Beam Therapeutics Inc. Shares - GuruFocus

GuruFocus - Feb 12, 2026

Beam Therapeutics Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily

Investor's Business Daily - Feb 09, 2026

How Investors Are Reacting To Beam Therapeutics (BEAM) ARK’s Renewed Bet On Base-Editing Biotech - Yahoo Finance

Yahoo Finance - Jan 06, 2026

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Biotech Innovator with 73% Potential Upside - DirectorsTalk Interviews

DirectorsTalk Interviews - Feb 10, 2026

Is Beam Therapeutics’ (BEAM) Alpha-1 Update Quietly Reframing the Story of Its Gene-Editing Platform? - simplywall.st

simplywall.st - Feb 02, 2026

Bernstein Maintains an Outperform Rating on Beam Therapeutics Inc. (BEAM) - Finviz

Finviz - Jan 29, 2026

Beam Therapeutics Senior Vice President Sells 6,198 Shares for $216,933 - The Motley Fool

The Motley Fool - Feb 01, 2026

Gene Editor Soars To 10-Month High On Bullish FDA News - Investor's Business Daily

Investor's Business Daily - Jan 12, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment